CClinicalTrials.gg
CompletedNCT06851455Updated Feb 28, 2025

Advancing Skills and Confidence in Ultrasound-Guided Injection Techniques: the Impact of a Cadaveric Workshop

An interventional study of Cadaveric Workshop on Ultrasound-guided Injections in Ultrasound-Guided Injection, Joint Diseases and Cadaveric Training, sponsored by Istanbul University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-28.

Sponsored by Istanbul University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Oct 2024, registered Feb 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
109
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The goal of this study is to assess whether a cadaveric ultrasound-guided injection workshop improves procedural skills and confidence among participant physicians. It will also evaluate participants' satisfaction and perceived clinical applicability.

The main questions it aims to answer are:

Does the workshop enhance participants' accuracy and confidence in performing ultrasound-guided musculoskeletal injections? How do participants rate the workshop's effectiveness in improving their clinical skills?

Participants will:

Attend a structured cadaveric workshop on ultrasound-guided musculoskeletal injections.

Perform hands-on procedures under expert supervision. Complete pre- and post-workshop assessments to measure skill improvement and confidence levels.

Read the detailed description

Ultrasound-guided musculoskeletal injections have become an essential skill in physical medicine and rehabilitation, orthopedic practice, and pain management. Despite their increasing use, mastering these techniques requires both theoretical knowledge and hands-on experience. Cadaveric training workshops provide a unique opportunity for physicians to refine their procedural skills in a controlled environment that closely mimics real-world clinical scenarios.

This study evaluates the effectiveness of a cadaveric musculoskeletal system ultrasound-guided injection workshop in enhancing the technical proficiency, confidence, and clinical readiness of physicians. By integrating structured didactic sessions with hands-on practice on cadaveric specimens, the workshop aims to bridge the gap between theoretical learning and clinical application.

Participants will undergo a comprehensive learning experience, beginning with instructional lectures covering the principles of ultrasound guidance, needle visualization techniques, and common musculoskeletal injection sites. Following this, they will engage in supervised hands-on practice on cadaveric specimens, allowing them to refine their accuracy in needle placement, optimize probe handling, and gain a deeper understanding of anatomical structures.

To assess the workshop's effectiveness, physicians will complete pre- and post-training evaluations, including objective assessments of their procedural accuracy and subjective self-reports on confidence levels. The study will analyze improvements in needle placement precision, injection efficiency, and participants' perceived ability to translate these skills into clinical practice.

By providing an immersive and interactive training experience, this study seeks to determine whether cadaveric workshops serve as a valuable tool in advancing physicians' competency in ultrasound-guided musculoskeletal injections. Findings from this research may contribute to the development of more structured training programs, ultimately improving patient outcomes in musculoskeletal care.

02

Conditions studied

  • Ultrasound-Guided Injection
  • Joint Diseases
  • Cadaveric Training

Browse trials for

Keywords

  • Ultrasound-guided injection
  • Cadaveric training
  • Musculoskeletal ultrasonography
  • Medical education
03

In context

Joint Diseases

712 studies on the registry are indexed under Joint Diseases; 127 are open to participants now.

This study's enrollment of 109 is above the median of 60 across 470 interventional studies indexed under Joint Diseases.

Browse Joint Diseases studies →

Lead sponsor

Istanbul University is the lead sponsor of 496 studies on the registry; 79 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Being a physician working in the field of Physical Medicine \& Rehabilitation
  • Participating in the cadaveric workshop
  • Signed the informed consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Unwilling to provide data for this study
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
109 participants (actual)

Study arms

  • Experimental
    Cadaveric Workshop Participants

    The arm is participant physicians for the workshop that are working in the department of physical medicine and rehabilitation. They are from different academic degrees such as residents, specialists and professors.

    Other: Cadaveric Workshop on Ultrasound-guided Injections

Interventions

  • OtherCadaveric Workshop on Ultrasound-guided Injections

    Participant physicians will attend a structured cadaveric workshop on ultrasound-guided musculoskeletal injections. Participants will perform hands-on procedures under expert supervision on lower extremity joints listed as hip, knee and ankle. For the assessment participants will be asked to complete pre- and post-workshop assessments to measure skill improvement and confidence levels.

06

What researchers measure

Primary outcomes

  1. Pre-Workshop Evaluation Survey

    A pre-workshop survey filled out by participants prior to the lectures, which contained question items about their age, sex, academic and professional experience in medicine and physiatry, prior exposure to MSK USG and injections, current access to ultrasound equipment, prior attendance at other ultrasound training programs, frequency of ultrasound-guided injections done in a week, and self-confidence regarding hip, knee and ankle ultrasound-guided injections using a 5-point Likert scale, with 0 denoting the least confidence and 4 denoting the highest.

    Time frame: Once at the beginning of the study, just before the workshop

  2. Post-Workshop Evaluation Survey

    A post-workshop survey filled out by participants after the workshop to assess their self-confidence in MSK ultrasound-guided injections regarding the three joints and the perceived value of the course. In addition, the usefulness of the course and contentment of participants about the materials used and quality of context were also measured using a 5-point Likert scale, where 0 indicated the least content and 4 the most content. At last, participants were invited to suggest regions, subjects and techniques they would like to have covered in upcoming ultrasonography seminars.

    Time frame: Once, immediately after the workshop

07

Study locations

1 site
  • Istanbul Kanuni Sultan Süleyman Training and Research Hospital, University of Health Sciences
    İstanbul, 34303, Turkey
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06851455
Lead sponsor
Istanbul University
Collaborators
Saglik Bilimleri Universitesi, Koç University
Responsible party
Mert Zure (Ass. Prof. Mert Zure, Saglik Bilimleri Universitesi) — Principal investigator
First posted
Feb 28, 2025
Start date
Oct 3, 2024
Primary completion
Nov 30, 2024
Completion
Nov 30, 2024
Last update
Feb 28, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion